Analysts’ Viewpoint on Collagen Peptide and Gelatin Market Scenario
Rise in population-wide concerns about health and wellness has created significant opportunities in the global collagen peptide and gelatin market. Increase in demand for nutraceuticals and research & development studies pertaining to novel drug delivery systems is propelling the global collagen peptide and gelatin market share. Demand for nutraceuticals is likely to rise significantly due to rising social awareness about individual wellbeing. Usage of collagen in food and beverage production is also increasing as well as the demand for dietary supplements. Application of collagen peptide and gelatin is increasing in the nutricosmetics, pharmaceutical, and healthcare industries. Furthermore, mergers & acquisitions and novel prebiotic/probiotic product launches that improve heart health are anticipated to boost the market.
Protein collagen is used in several fields, including food, biomedicine, and skincare. Various beneficial properties of collagen support its usage as a potential biomaterial as compared to other natural polymers and their synthetic equivalents. Collagen is a highly preferred biomaterial due to its biological properties such as high biocompatibility, biodegradability, and low antigenicity. Approximately 30% of all proteins in the body are made of this protein, which is primarily found in bones, ligaments, and tendons. These collagen peptides are also known as hydrolysed collagen. Primary sources of collagen are cattle, pigs, and fish, while minor sources include chicken, equines, rat tails, silkworms, and sheep. Gelatin is also known as a multifunctional ingredient due to its properties, such as gelation, water binding, foaming, elasticity, binding, emulsifying, film forming, and viscosity, which provide texture and stability to products. Several companies are focusing on these products, as the demand is increasing. This, in turn, is fueling the gelatin market and collagen peptide market.
Demand for nutritional supplements, such as collagen peptide and hydrolyzed gelatin, has increased due to rise in focus on health and lifestyle. People are choosing functional foods and nutraceuticals to ward off age-related illnesses and enhance quality of life. Applications of nutraceuticals are increasing due to factors such as easy accessibility, affordability, and awareness. The geriatric population and athletes use nutraceuticals, as these are rich sources of proteins and other essential supplements. The European Nutraceutical Association (ENA) estimates that malnutrition was responsible for 38.6% of deaths in developing countries such as China, India, and Brazil. Therefore, nutritional deficiencies are caused by the types of food that people eat, not by their socioeconomic class. Increase in age-related health concerns, economic growth, rise in health awareness, surge in geriatric population, and changing lifestyles are increasing the demand for nutraceuticals.
Collagen-based drug delivery products used in various disease areas include collagen sponges, shields, liposomes, microspheres, and nanoparticles. Liposomes and nanoparticles are novel types of collagen-based drug delivery system for sustained release. Collagen is also widely used in the encapsulation of active pharmaceutical ingredients (API) to protect them from disintegration in acidic gastric juices.
Liposomes are superior carriers because these can encapsulate both hydrophilic and lipophilic drugs and protect them from degradation. Furthermore, they improve absorption rates and can function as an efficient solubilizing matrix. Liposome gel formulations outperform conventional formulations, resulting in higher patient compliance and efficacy. These advantages lead to increased acceptance of collagen-based liposome drug delivery systems, which in turn drives the collagen market. In comparison to other synthetic polymers, protein-based nano carriers (such as collagen, elastin, and fibronectin) have shown to be advantageous due to their low toxicity, lack of immunogenicity, high stability, and high nutritional value. Collagen nanoparticles possess high capacity for adsorption and high dispersion ability in water, which enables high sustained release of different drugs.
In terms of product type, the global collagen peptide and gelatin market has been bifurcated into collagen peptide and gelatin. Gelatin is known as a multifunctional ingredient because of its properties such as gelation, water binding, foaming, elasticity, binding, emulsifying, film forming, and viscosity, which drives its usage in various products. Utilization of gelatin to treat health-related issues, such as arthritis and joint pain, is increasing significantly, as it also aids in the treatment of skin and hair issues. Moreover, it is widely used in the manufacturing process of products that cater to wound healing market and empty capsule market.
Based on source, the global collagen peptide and gelatin market has been segregated into bovine, porcine, poultry, marine, and others. The bovine segment dominated the global market in 2021. The segment is driven by rise in demand for bovine-based collagen in the treatment of osteoporosis, osteoarthritis, and even skin-related diseases.
Based on application, the global collagen peptide and gelatin market has been divided into pharmaceuticals, food & beverages, cosmeceuticals, nutraceuticals, and others. The food & beverages segment dominated the global market in 2021. Gelatin is used more often in food production processes to produce diets high in protein. Gelatin is used as an active ingredient in the creation of capsules and hard gels due to its capacity to shield delicate contents from air and microbial growth. Additionally, it can be utilized in various food products owing to its neutral flavor and ability to blend with various flavors.
North America is expected to dominate the global market during the forecast period. Well-established health-care infrastructure, technological advancement in innovative treatment, and favorable government support contribute to the dominance of the region in the global market. Presence of well-established collagen manufacturing facilities and usage of advanced extraction methodologies are driving the market in the U.S. Increase in R&D activities is likely to drive the development of novel drug formulations. This in turn is projected to lead to the introduction of collagen-based products, such as bone graft substitutes and wound repair products, and consequently, lead to growth of novel drug delivery systems market.
Europe held the second-largest share of the global collagen peptide and gelatin market in 2021. The region offers significant opportunities to market participants focused on the introduction of collagen-based products. The collagen peptide and gelatin market trends in Europe indicate rapid growth during the forecast period. However, a closer assessment of the collagen peptide and gelatin market analysis reveals that it is likely to face some challenges, including a rise in the threat of external substitutes, such as vegetables, to boost the collagen-producing capability and growing concerns about the quality of collagen-based products. These factors are likely to retrain the collagen market in Europe.
Developing countries in Asia Pacific are projected to present lucrative growth opportunities in the collagen peptide and gelatin market due to production of cost-effective collagen and availability of skilled labor. Rapid growth of the pharmaceutical manufacturing industry in Asia Pacific, increase in number of food processing units, and rise in public awareness about nutritional dietary supplements are propelling the demand for collagen peptide products in the region.
The global collagen peptide and gelatin market is fragmented, with the presence of a large number of large-scale players. Key players operating in the global collagen peptide and gelatin market include Amicogen, BioCell Technology LLC, Lonza Group Ltd., Nitta Gelatin, Inc., GELITA AG, Norland Products, Inc., Gelnex, Ewald-Gelatine GmbH, and Tessenderlo Group NV. These players are adopting growth strategies such as new product development, product launches, product approval, agreement, partnerships, and mergers.
Each of these players has been profiled in the collagen peptide and gelatin market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
Attribute | Detail |
---|---|
Market Size Value in 2021 | US$ 4.8 Bn |
Market Forecast Value in 2031 | More than US$ 7.8 Bn |
Growth Rate (CAGR) 2022-2031 | 5.0% |
Forecast Period | 2022–2031 |
Historical Data Available for | 2017–2021 |
Quantitative Units | US$ Bn for Value |
Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
Competition Landscape |
|
Format | Electronic (PDF) + Excel |
Market Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope | Available upon request |
Pricing | Available upon request |
The global collagen peptide and gelatin market was valued at US$ 4.8 Bn in 2021.
The global collagen peptide and gelatin market is projected to reach more than US$ 7.8 Bn by 2031.
The global collagen peptide and gelatin market grew at a CAGR of 4.6% from 2017 to 2021.
The global collagen peptide and gelatin market is anticipated to grow at a CAGR of 5.0% from 2022 to 2031.
The gelatin segment held major share of around 68% of the global collagen peptide and gelatin market in 2021.
North America is expected to account for major share of the global collagen peptide and gelatin market during the forecast period.
Amicogen, BioCell Technology LLC, Lonza Group Ltd., Nitta Gelatin, Inc., GELITA AG, Norland Products, Inc., Gelnex, Ewald-Gelatine GmbH, and Tessenderlo Group NV.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Collagen Peptide and Gelatin Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definitions
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Collagen Peptide and Gelatin Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key product/brand Analysis
5.2. Key Mergers & Acquisitions
5.3. Covid-19 Impact Analysis
6. Global Collagen Peptide and Gelatin Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017-2031
6.3.1. Collagen Peptide
6.3.2. Gelatin
6.4. Market Attractiveness Analysis, by Product Type
7. Global Collagen Peptide and Gelatin Market Analysis and Forecast, by Source
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Source, 2017-2031
7.3.1. Bovine
7.3.2. Porcine
7.3.3. Poultry
7.3.4. Marine
7.3.5. Others
7.4. Market Attractiveness Analysis, by Source
8. Global Collagen Peptide and Gelatin Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2017-2031
8.3.1. Pharmaceuticals
8.3.2. Food & Beverages
8.3.3. Cosmeceuticals
8.3.4. Nutraceuticals
8.3.5. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Collagen Peptide and Gelatin Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Collagen Peptide and Gelatin Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017-2031
10.2.1. Collagen Peptide
10.2.2. Gelatin
10.3. Market Value Forecast, by Source, 2017-2031
10.3.1. Bovine
10.3.2. Porcine
10.3.3. Poultry
10.3.4. Marine
10.3.5. Others
10.4. Market Value Forecast, by Application, 2017-2031
10.4.1. Pharmaceuticals
10.4.2. Food & Beverages
10.4.3. Cosmeceuticals
10.4.4. Nutraceuticals
10.4.5. Others
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Source
10.6.3. By Application
10.6.4. By Country
11. Europe Collagen Peptide and Gelatin Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017-2031
11.2.1. Collagen Peptide
11.2.2. Gelatin
11.3. Market Value Forecast, by Source, 2017-2031
11.3.1. Bovine
11.3.2. Porcine
11.3.3. Poultry
11.3.4. Marine
11.3.5. Others
11.4. Market Value Forecast, by Application, 2017-2031
11.4.1. Pharmaceuticals
11.4.2. Food & Beverages
11.4.3. Cosmeceuticals
11.4.4. Nutraceuticals
11.4.5. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Source
11.6.3. By Application
11.6.4. By Country/Sub-region
12. Asia Pacific Collagen Peptide and Gelatin Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017-2031
12.2.1. Collagen Peptide
12.2.2. Gelatin
12.3. Market Value Forecast, by Source, 2017-2031
12.3.1. Bovine
12.3.2. Porcine
12.3.3. Poultry
12.3.4. Marine
12.3.5. Others
12.4. Market Value Forecast, by Application, 2017-2031
12.4.1. Pharmaceuticals
12.4.2. Food & Beverages
12.4.3. Cosmeceuticals
12.4.4. Nutraceuticals
12.4.5. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia and New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Source
12.6.3. By Application
12.6.4. By Country/Sub-region
13. Latin America Collagen Peptide and Gelatin Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017-2031
13.2.1. Collagen Peptide
13.2.2. Gelatin
13.3. Market Value Forecast, by Source, 2017-2031
13.3.1. Bovine
13.3.2. Porcine
13.3.3. Poultry
13.3.4. Marine
13.3.5. Others
13.4. Market Value Forecast, by Application, 2017-2031
13.4.1. Pharmaceuticals
13.4.2. Food & Beverages
13.4.3. Cosmeceuticals
13.4.4. Nutraceuticals
13.4.5. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Source
13.6.3. By Application
13.6.4. By Country/Sub-region
14. Middle East & Africa Collagen Peptide and Gelatin Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017-2031
14.2.1. Collagen Peptide
14.2.2. Gelatin
14.3. Market Value Forecast, by Source, 2017-2031
14.3.1. Bovine
14.3.2. Porcine
14.3.3. Poultry
14.3.4. Marine
14.3.5. Others
14.4. Market Value Forecast, by Application, 2017-2031
14.4.1. Pharmaceuticals
14.4.2. Food & Beverages
14.4.3. Cosmeceuticals
14.4.4. Nutraceuticals
14.4.5. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Source
14.6.3. By Application
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Amicogen
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. BioCell Technology LLC
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Lonza Group Ltd.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Nitta Gelatin, Inc.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. GELITA AG
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Norland Products, Inc.
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Gelnex
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Ewald-Gelatine GmbH
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Tessenderlo Group NV
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Others Prominent Players
List of Tables
Table 01: Global Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 02: Global Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Collagen Peptide, 2017-2031
Table 03: Global Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Gelatin, 2017-2031
Table 04: Global Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Source, 2017-2031
Table 05: Global Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 06: Global Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 07: North America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 08: North America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 09: North America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Collagen Peptide, 2017-2031
Table 10: North America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Gelatin 2017-2031
Table 11: North America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Source 2017-2031
Table 12: North America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 13: Europe Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031
Table 14: Europe Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 15: Europe Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Collagen Peptide, 2017-2031
Table 16: Europe Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Gelatin 2017-2031
Table 17: Europe Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Source, 2017-2031
Table 18: Europe Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 19: Asia Pacific Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 20: Asia Pacific Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 21: Asia Pacific Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Collagen Peptide, 2017-2031
Table 22: Asia Pacific Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Gelatin, 2017-2031
Table 23: Asia Pacific Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Source, 2017-2031
Table 24: Asia Pacific Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 25: Latin America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 26: Latin America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 27: Latin America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Collagen Peptide, 2017-2031
Table 28: Latin America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Gelatin, 2017-2031
Table 29: Latin America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Source, 2017-2031
Table 30: Latin America Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 31: Middle East & Africa Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 32: Middle East & Africa Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 33: Middle East & Africa Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Collagen Peptide, 2017-2031
Table 34: Middle East & Africa Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Gelatin 2017-2031
Table 35: Middle East & Africa Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Source, 2017-2031
Table 36: Middle East & Africa Collagen Peptide & Collagen Market Value (US$ Mn) Forecast, by Application, 2017-2031
List of Figures
Figure 01: Global Collagen Peptide and Gelatin Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Collagen Peptide and Gelatin Market Value Share, by Product Type, 2021
Figure 03: Global Collagen Peptide and Gelatin Market Value Share, by Source, 2021
Figure 04: Global Collagen Peptide and Gelatin Market Value Share, by Application, 2021
Figure 05: Global Collagen Peptide and Gelatin Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 06: Global Collagen Peptide and Gelatin Market Attractiveness Analysis, by Product Type, 2022-2031
Figure 07: Global Collagen Peptide and Gelatin Market Value (US$ Mn), by Collagen Peptide, 2017-2031
Figure 08: Global Collagen Peptide and Gelatin Market Value (US$ Mn), by Gelatin, 2017-2031
Figure 09: Global Collagen Peptide and Gelatin Market Value Share Analysis, by Source, 2021 and 2031
Figure 10: Global Collagen Peptide and Gelatin Market Attractiveness Analysis, by Source, 2022-2031
Figure 11: Global Collagen Peptide and Gelatin Market Revenue (US$ Mn), by Bovine, 2017-2031
Figure 12: Global Collagen Peptide and Gelatin Market Revenue (US$ Mn), by Porcine, 2017-2031
Figure 13: Global Collagen Peptide and Gelatin Market Revenue (US$ Mn), by Poultry, 2017-2031
Figure 14: Global Collagen Peptide and Gelatin Market Revenue (US$ Mn), by Marine, 2017-2031
Figure 15: Global Collagen Peptide and Gelatin Market Revenue (US$ Mn), by Others, 2017-2031
Figure 16: Global Collagen Peptide and Gelatin Market Value Share Analysis, by Application, 2021 and 2031
Figure 17: Global Collagen Peptide and Gelatin Market Attractiveness Analysis, by Application, 2022-2031
Figure 18: Global Collagen Peptide and Gelatin Market Revenue (US$ Mn), by Pharmaceuticals, 2017-2031
Figure 19: Global Collagen Peptide and Gelatin Market Revenue (US$ Mn), by Food & Beverages, 2017-2031
Figure 20: Global Collagen Peptide and Gelatin Market Revenue (US$ Mn), by Cosmeceuticals, 2017-2031
Figure 21: Global Collagen Peptide and Gelatin Market Revenue (US$ Mn), by Nutraceuticals, 2017-2031
Figure 22: Global Collagen Peptide and Gelatin Market Revenue (US$ Mn), by Others, 2017-2031
Figure 23: Global Collagen Peptide and Gelatin Market Value Share Analysis, by Region, 2021 and 2031
Figure 24: Global Collagen Peptide and Gelatin Market Attractiveness Analysis, by Region, 2022-2031
Figure 25: North America Collagen Peptide and Gelatin Market Value (US$ Mn) Forecast, 2017-2031
Figure 26: North America Collagen Peptide and Gelatin Market Value Share Analysis, by Country, 2021 and 2031
Figure 27: North America Collagen Peptide and Gelatin Market Attractiveness Analysis, by Country, 2022-2031
Figure 28: North America Collagen Peptide and Gelatin Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 29: North America Collagen Peptide and Gelatin Market Attractiveness Analysis, by Product Type, 2022-2031
Figure 30: North America Collagen Peptide and Gelatin Market Value Share Analysis, by Source, 2021 and 2031
Figure 31: North America Collagen Peptide and Gelatin Market Attractiveness Analysis, by Source, 2022-2031
Figure 32: North America Collagen Peptide and Gelatin Market Value Share Analysis, by Application, 2021 and 2031
Figure 33: North America Collagen Peptide and Gelatin Market Attractiveness Analysis, by Application, 2022-2031
Figure 34: Europe Collagen Peptide and Gelatin Market Value (US$ Mn) Forecast, 2017-2031
Figure 35: Europe Collagen Peptide and Gelatin Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 36: Europe Collagen Peptide and Gelatin Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 37: Europe Collagen Peptide and Gelatin Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 38: Europe Collagen Peptide and Gelatin Market Attractiveness Analysis, by Product Type, 2022-2031
Figure 39: Europe Collagen Peptide and Gelatin Market Value Share Analysis, by Source, 2021 and 2031
Figure 40: Europe Collagen Peptide and Gelatin Market Attractiveness Analysis, by Source, 2022-2031
Figure 41: Europe Collagen Peptide and Gelatin Market Value Share Analysis, by Application, 2021 and 2031
Figure 42: Europe Collagen Peptide and Gelatin Market Attractiveness Analysis, by Application, 2022-2031
Figure 43: Asia Pacific Collagen Peptide and Gelatin Market Value (US$ Mn) Forecast, 2017-2031
Figure 44: Asia Pacific Collagen Peptide and Gelatin Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 45: Asia Pacific Collagen Peptide and Gelatin Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 46: Asia Pacific Collagen Peptide and Gelatin Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 47: Asia Pacific Collagen Peptide and Gelatin Market Attractiveness Analysis, by Product Type, 2022-2031
Figure 48: Asia Pacific Collagen Peptide and Gelatin Market Value Share Analysis, by Source, 2021 and 2031
Figure 49: Asia Pacific Collagen Peptide and Gelatin Market Attractiveness Analysis, by Source, 2022-2031
Figure 50: Asia Pacific Collagen Peptide and Gelatin Market Value Share Analysis, by Application, 2021 and 2031
Figure 51: Asia Pacific Collagen Peptide and Gelatin Market Attractiveness Analysis, by Application, 2022-2031
Figure 52: Latin America Collagen Peptide and Gelatin Market Value (US$ Mn) Forecast, 2017-2031
Figure 53: Latin America Collagen Peptide and Gelatin Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031
Figure 54: Latin America Collagen Peptide and Gelatin Market Attractiveness Analysis, by Country/Sub-Region, 2021-2031
Figure 55: Latin America Collagen Peptide and Gelatin Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 56: Latin America Collagen Peptide and Gelatin Market Attractiveness Analysis, by Product Type, 2022-2031
Figure 57: Latin America Collagen Peptide and Gelatin Market Value Share Analysis, by Source, 2021 and 2031
Figure 58: Latin America Collagen Peptide and Gelatin Market Attractiveness Analysis, by Source, 2022-2031
Figure 59: Latin America Collagen Peptide and Gelatin Market Value Share Analysis, by Application, 2021 and 2031
Figure 60: Latin America Collagen Peptide and Gelatin Market Attractiveness Analysis, by Application, 2022-2031
Figure 61: Middle East & Africa Collagen Peptide and Gelatin Market Value (US$ Mn) Forecast, 2017-2031
Figure 62: Middle East & Africa Collagen Peptide and Gelatin Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031
Figure 63: Middle East & Africa Collagen Peptide and Gelatin Market Attractiveness Analysis, by Country/Sub-Region, 2021-2031
Figure 64: Middle East & Africa Collagen Peptide and Gelatin Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 65: Middle East & Africa Collagen Peptide and Gelatin Market Attractiveness Analysis, by Product Type, 2022-2031
Figure 66: Middle East & Africa Collagen Peptide and Gelatin Market Value Share Analysis, by Source, 2021 and 2031
Figure 67: Middle East & Africa Collagen Peptide and Gelatin Market Attractiveness Analysis, by Source, 2022-2031
Figure 68: Middle East & Africa Collagen Peptide and Gelatin Market Value Share Analysis, by Application, 2021 and 2031
Figure 69: Middle East & Africa Collagen Peptide and Gelatin Market Attractiveness Analysis, by Application, 2022-2031
Figure 70: Company Share Analysis, 2021